Effect of p53 overexpression on radiation sensitivity of human colon cancer cells

Radiation Oncology Investigations

Volumn 5, Issue 2, 1997, Pages 43-49

  Zellars, Richard C ^a   Naida, John D ^a   Davis, Mary A ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Cell cycle; p53; Radiation sensitivity

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; COLON CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; HT29 CELLS; HUMANS; PREDICTIVE VALUE OF TESTS; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030873942     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1997)5:2<43::AID-ROI1>3.0.CO;2-J     Document Type: Article

References (30)

1. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: P53 status and the efficacy of cancer therapy in vivo. Science 266:807-810, 1994.
2. Brachman DG, Beckett M, Graves D, Haraf D, Yokes E, Weichelsbaum R: p53 Mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53:3667-3669, 1993.
3. Jung M, Notario V, Dritschilo A: Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells. Cancer Res 52:6390-6393, 1992.
4. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53:164-168, 1993.
5. Servomaa K, Kiuru A, Grenman R, Pekkola-Heino K, Pulkkinen JO, Rytomaa T: p53 Mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 29(5): 219-230, 1996.
6. Gjerset RA, Turla ST, Sobol RE, Scalise JJ, Mercola D, Collins H, Hopkins PJ: Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53. Mol Carcinogenesis 14(4): 275-285, 1995.
7. Fan S, el Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW, O'Connor PM: p53 Gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54(22):5824-5830, 1994.
8. Huang H, Li CY, Little JB: Abrogation of p53 function by transfection of 2HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. Int J Radiat Biol 70(2):151-160, 1996.
9. Tsang NM, Nagasawa H, Li C, Little JB: Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 10(12):2403-2408, 1995.
10. Kasid UN, Weichselbaum RR, Brennan T, Mark GE, Dritschilo A: Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: Significance for gene transfer studies. Cancer Res 49:3396-3400, 1989.
11. Ginsberg D, Michael-Michalovitz D, Ginsberg D, Oren M: Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol 11:582-585, 1991.
12. Michalovitz D, Halvey O, Orens M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680, 1990.
13. L protein content in HT29 cells. Oncogene 13:2631-2637, 1996.
14. Lawrence TS, Davis MA, Maybaum J, Mukhopadhay SK, Stetson PL, Normolle DP, McKeever PE, Ensminger WD: The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Cancer Res 52: 3698-3704, 1992.
15. Fertil B, Dertinger H, Courdi A, Malaise EP: Mean inactivation dose: A useful concept for intercomparison of human cell survival curves. Radiat Res 99:73-84, 1984.
16. Hoy CA, Seamer LC, Schimke RT: Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): Critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram. Cytometry 10:718-725, 1989.
17. Childs S, Yeh RL, Georges E, Ling V: Identification of a sister gene to P-glycoprotein. Cancer Res 55:2029-2034, 1995.
18. Wilt SR, Burgess AC, Normolle DP, Trent JM, Lawrence TS: Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells. Int J Radiat Oncol Biol Phys 30:861-866, 1994.
19. Terasima T, Tolmach LJ: Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophysics J 3:11-33, 1963.
20. Sinclair WK: Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 33:620-643, 1968.
21. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993.
22. Yonish-Rouach E, Resnitzky D, Lotem J, Sach L, Kimichi A, Oren M: Wild type p53 induced apoptosis of myeloid leukemic cells that are inhibited by interleukin 6. Nature 352:345-347, 1991.
23. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821-1828, 1994.
24. Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC, Israel MA: Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 56:500-506, 1996.
25. Kastan MB, Onyekwere O, Sidransky D, Volgestein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311, 1991.
26. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB: Wild type p53 is a cell cycle check point determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495, 1992.
27. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92:8493-8497, 1995.
28. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356, 1995.
29. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965, 1991.
30. Fukunaga-Johnson N, Ryan JJ, Wicha M, Nunez G, Clark MF: Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death. Carcinogenesis 16:1761-1767, 1995.